Lung Cancer

« Later Stage Treatment »

What Do Checkpoint Inhibitors Do For Cancer?

Dr. Scott Strome University of Maryland

Autoimmune diseases mean that the body is attacking its own cells. Researchers developing cancer drugs are attempting to recreate that effect. But instead of the immune system attacking itself, it will be trained to attack the tumor or the malignant cells. This is what doctors are referring to when they talk about checkpoint inhibition.

Checkpoint inhibitors are man-made antibodies that shut down key proteins on immune cells like PD-L1 – essentially halting a cancer’s ability to spread. Checkpoint inhibitors have been proven effective for certain later-stage cancers, but the genetic codes in certain people may inhibit their positive effects. In order to know if you’re a viable candidate for checkpoint inhibitors as a treatment for your later stage cancer, check with your doctor. They’ll go over your hereditary information to determine if it’s one of your best options.

Learn more about SurvivorNet's rigorous medical review process.


Dr. Scott Strome is the chair of the Department of Otorhinolaryngology Head & Neck Surgery at University of Maryland School of Medicine. Read More

Late Stage Lung Cancer

Late stage lung cancer means that the disease has spread to other organs. The goal in these cases is to treat the whole body, destroying all the cancer cells. There are several options for how to approach treating stage four lung cancers.